Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Advances in breast imaging: magnetic resonance imaging.

Literature DB >> 16464397

Advances in breast imaging: magnetic resonance imaging.

Abstract

Magnetic resonance imaging (MRI) of the breast is rapidly becoming incorporated into clinical practice. Indications for breast MRI include staging of known breast cancer, monitoring response to chemotherapy, assessing recurrence, problem solving, and high-risk screening. Magnetic resonance spectroscopy is a promising technique that may decrease the number of benign biopsies generated by breast MRI in the clinical setting.

Entities: Disease

Mesh：

Year: 2006 PMID： 16464397 DOI： 10.1007/s11912-006-0003-y

Source DB: PubMed Journal: Curr Oncol Rep ISSN： 1523-3790 Impact factor: 5.075

57 in total

1. Review of breast MRI: indications and limitations.

Authors: E A Morris
Journal: Semin Roentgenol Date: 2001-07 Impact factor: 0.800

2. In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging.

Authors: P Viehweg; D Lampe; J Buchmann; S H Heywang-Köbrunner
Journal: MAGMA Date: 2000-12 Impact factor: 2.310

Review 3. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy.

Authors: M V Knopp; G Brix; H J Junkermann; H P Sinn
Journal: Magn Reson Imaging Clin N Am Date: 1994-11 Impact factor: 2.266

4. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy.

Authors: K A Kvistad; I J Bakken; I S Gribbestad; B Ehrnholm; S Lundgren; H E Fjøsne; O Haraldseth
Journal: J Magn Reson Imaging Date: 1999-08 Impact factor: 4.813

5. MRI of the breast in patients with metastatic disease of unknown primary.

Authors: C Schorn; U Fischer; S Luftner-Nagel; J P Westerhof; E Grabbe
Journal: Eur Radiol Date: 1999 Impact factor: 5.315

6. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T.

Authors: Sina Meisamy; Patrick J Bolan; Eva H Baker; Robin L Bliss; Evin Gulbahce; Lenore I Everson; Michael T Nelson; Tim H Emory; Todd M Tuttle; Douglas Yee; Michael Garwood
Journal: Radiology Date: 2004-11 Impact factor: 11.105

7. Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging.

Authors: T H Dao; A Rahmouni; F Campana; M Laurent; B Asselain; A Fourquet
Journal: Radiology Date: 1993-06 Impact factor: 11.105

8. MRI of occult breast carcinoma in a high-risk population.

Authors: Elizabeth A Morris; Laura Liberman; Douglas J Ballon; Mark Robson; Andrea F Abramson; Alexandra Heerdt; D David Dershaw
Journal: AJR Am J Roentgenol Date: 2003-09 Impact factor: 3.959

9. Contrast-enhanced MR imaging of breast lesions and effect on treatment.

Authors: K Schelfout; M Van Goethem; E Kersschot; C Colpaert; A M Schelfhout; P Leyman; I Verslegers; I Biltjes; J Van Den Haute; J P Gillardin; W Tjalma; J C Van Der Auwera; P Buytaert; A De Schepper
Journal: Eur J Surg Oncol Date: 2004-06 Impact factor: 4.424

Advances in breast imaging: magnetic resonance imaging.

1. Review of breast MRI: indications and limitations.

2. In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging.

Review 3. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy.

4. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy.

5. MRI of the breast in patients with metastatic disease of unknown primary.

6. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T.

7. Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging.

8. MRI of occult breast carcinoma in a high-risk population.

9. Contrast-enhanced MR imaging of breast lesions and effect on treatment.

10. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy.

1. [Functional and molecular imaging of breast tumors].

2. Molecular Imaging in Breast Cancer - Potential Future Aspects.

3. Differential diagnosis between malignant and benign breast lesions using single-voxel proton MRS: a meta-analysis.

4. Computed tomography for imaging the breast.

5. Diffusion-weighted imaging in breast lesion evaluation.

6. An X-Ray computed tomography/positron emission tomography system designed specifically for breast imaging.